$202.19+$1.57 (+0.78%)as of market close, Jul 24, 2026
BIIB — Biogen Inc. stock price, chart and key statistics
Key stats
Price data
- Price
- $202.19
- Change YTD
- +13.70%
- Next earnings
- Jul 29, 2026 · Before open
- Market cap
- 29.9B
- Enterprise value
- 32.8B
- Shares outstanding
- 147.6M
- 52W low
- $124.56
- 52W high
- $219.72
- From 52W high
- -7.98%
- From 52W low
- +62.32%
- 52W range
- 82%
- Beta
- 0.16
Volume
- Rel volume
- 0.61×
- 30D volume
- 1.4M
- 30D $ vol
- 274M
Fundamentals
- Sales (ttm)
- 9.9B
- Sales/share
- $67.31
- EPS (ttm)
- $9.24
- FCF (ttm)
- 2.4B
- FCF/share
- $16.41
- Book value/share
- $126.33
- Net margin
- 13.81%
- ROE
- 7.36%
- ROA
- 4.65%
- Debt / equity
- 0.34×
- Current ratio
- 3.06
Growth (CAGR, ttm) · 10Y
- Sales
- -0.95%
- Net income
- -9.44%
- FCF
- -3.69%
- Shares
- -3.87%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -5.50%
- Sales/share
- +3.03%
- FCF/share
- +0.18%
- Book value/share
- +10.36%
- Price
- -3.47%
- Total return
- -3.47%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 21.8×
- Fwd P/E
- 12.2×
- P/S (ttm)
- 3.0×
- P/B (mrq)
- 1.6×
- P/FCF (ttm)
- 12.3×
- EV/EBITDA (fy)
- 9.0×
- EV/Sales (ttm)
- 3.3×
- FCF yield (ttm)
- 8.12%
- Buyback yield (ttm)
- 0.00%
- Shareholder yield (ttm)
- 0.00%
Vs own 10Y history
- P/E
- 75th
- P/S
- 30th
- P/B
- 17th
- P/FCF
- 46th
Bar = where today's multiple sits in BIIB's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance
1D
+0.78%
1W
-1.84%
1M
+1.30%
3M
+7.62%
YTD
+13.70%
1Y
+54.37%
5Y
-37.71%
Financial statements
Open full BIIB financials →Related Healthcare
1MBiogen Inc. (BIIB) trades at $202.19 with a live price and an interactive chart covering 34+ years of daily price history, plus key valuation metrics. ChartRow also publishes BIIB's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full BIIB financial statements →
